Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stjepko, Plestina"'
Autor:
Anuska Budisavljevic, Renata Kelemenic-Drazin, Tajana Silovski, Stjepko Plestina, Natalija Dedic Plavetic
Publikováno v:
Supportive Care in Cancer. 31
Purpose Oncologists are predisposed to developing burnout syndrome. Like other health care professionals worldwide, oncologists have endured additional, extreme challenges during the Covid-19 pandemic. Psychological resilience presents a potential pr
Publikováno v:
Public Health Genomics. 25:70-79
Objectives: “Personalized healthcare” is generating new approaches to disease management by considering inter-individual variability in genes, environment, and lifestyle. Technologies such as comprehensive genomic profiling (CGP) are drivers of t
Autor:
Anuska, Budisavljevic, Renata, Kelemenic-Drazin, Natalija, Dedic Plavetic, Iva, Kardum Fucak, Tajana, Silovski, Vesna, Telesmanic Dobric, Mario, Nalbani, Zvonko, Curic, Zvjezdana, Boric-Mikez, Tatjana, Ladenhauser, Stjepko, Plestina
Publikováno v:
Psychiatria Danubina. 33(Suppl 13)
Information on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), later termed coronavirus disease (COVID-19), first emerged by the end of 2019. As the pandemic spread, cancer patients were immediately recognized as a high-risk populat
Autor:
Weijiang, Zhang, Christine, McIntyre, Harper, Forbes, Rabab, Gaafar, Hanaa, Kohail, J Thaddeus, Beck, Stjepko, Plestina, Enric, Bertran, Todd, Riehl
Publikováno v:
Clinical pharmacology in drug development. 8(6)
Vemurafenib prolongs survival in patients with BRAF
Autor:
Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Guminski, Grant R Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Enrique Fein, Michael Brown, Andrew Haydon, Adnan Khattak, Catriona McNeil, Phillip Parente, Jeremy Power, Rachel Roberts-Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas Berger, Ahmad Awada, Nathalie Blockx, Veronique Buyse, Jeroen Mebis, Fábio André Franke, Sérgio Jobim de Azevedo, Nicolas Silva Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa Petrella, Kerry Savage, Xinni Song, Ralph Wong, Nina Dabelic, Stjepko Plestina, Zeljko Vojnovic, Petr Arenberger, Ivo Kocak, Ivana Krajsova, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchova, Kadri Putnik, Brigitte Dreno, Caroline Dutriaux, Jean-Jacques Grob, Pascal Joly, Jean-Philippe Lacour, Nicolas Meyer, Laurent Mortier, Luc Thomas, Michael Fluck, Thilo Gambichler, Jessica Hassel, Axel Hauschild, Paul Donnellan, John McCaffrey, Derek Power, Samuel Ariad, Gil Bar-Sela, Daniel Hendler, Ilan Ron, Jacob Schachter, Paolo Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Paula Ferreira, Georgy Gafton, Yulia Makarova, Zoran Andric, Nada Babovic, Darjana Jovanovic, Lidija Kandolf Sekulovic, Graham Cohen, Lydia Dreosti, Daniel Vorobiof, Maria Teresa Curiel Garcia, Roberto Diaz Beveridge, Margarita Majem Tarruella, Ivan Marquez Rodas, Jose-M Puliats Rodriguez, Antonio Rueda Dominguez, Marianne Maroti, Karin Papworth, Olivier Michielin, Ewan Brown, Pippa Corrie, Mark Harries, Satish Kumar, Agustin Martin-Clavijo, Mark Middleton, Poulam Patel, Toby Talbot, Sanjiv Agarwala, Paul Chapman, Robert Conry, Gary Doolittle, Tara Gangadhar, Sigrun Hallmeyer, Omid Hamid, Leonel Hernandez-Aya, Douglas Johnson, Frederic Kass, Tatjana Kolevska, Scott Lunin, April Salama, Branimir Sikic, Bradley Somer, David Spigel, Eric Whitman
Summary Background Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study evaluated adjuvant vemurafenib monotherapy in patients with resected, BRAF V600 muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ca377ad3c682462789b57095f06c16
http://hdl.handle.net/11379/501841
http://hdl.handle.net/11379/501841
Autor:
Domina, Kekez, Sasa, Badzek, Juraj, Prejac, Irma, Gorsic, Hilda, Golem, Niksa, Librenjak, Drazen, Perkov, Ranko, Smiljanic, Stjepko, Plestina
Publikováno v:
Tumori Journal. 100:499-503
Safety evaluation of concomitant systemic chemotherapy and liver chemoembolization in patients with colorectal cancer.Seven patients with metastases confined to the liver were included and stratified into two groups, depending of dosage of systemic c
Autor:
Marin Mladinić, Jasenka Piljac-Žegarac, Nevenka Kopjar, Stjepko Plestina, Suzana Berend, Ana Lucić Vrdoljak, Božica Radić, Kamil Kuca, Davor Želježić
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 105:401-409
Some compounds, although not primarily designed as supportive drugs in chemotherapy, are promising candidates for clinical use. The ability of HI-6 oxime to relieve the side effects of irinotecan was recently determined in vitro. In this animal study
Autor:
Petra, Nola-Fuchs, Vanja Vucićević, Boras, Vanda, Plecko, Stjepko, Plestina, Aleksandar, Milenović, Mato, Susić, Vlaho, Brailo
Publikováno v:
Acta clinica Croatica. 51(4)
It has been suggested that certain viruses such as human papillomaviruses (HPV) and Epstein-Barr virus (EBV) might have a role in oral squamous cell carcinoma (OSCC). However, results of the published studies are controversial and are dependent on th
Autor:
Miljenko, Solter, Darko, Katalinić, Vesna, Vargek-Solter, Karolina, Dobrović, Andreja, Marić, Ljubica, Posavec, Darko, Solter, Stjepko, Plestina
Publikováno v:
Acta clinica Croatica. 51(2)
The purpose of our study was to contribute to better understanding of cerebrospinal fluid (CSF) as a valuable biological material in the research of brain tumors within the "low T3 syndrome", and to discuss the role of thyroid hormones in the central
Autor:
Sasa, Badzek, Ilijan, Tomas, Ivan, Krajina, Katarina, Pućo, Vesna Lesko, Kelović, Zdenko, Krajina, Stjepko, Plestina
Publikováno v:
Lijecnicki vjesnik. 131(11-12)
To avoid, or at least to reduce complications in patients who require head and neck radiotherapy, adequate oral cavity treatment is necessary before the therapy. Recent management guidelines speak of possibilities of preventing osteoradionecrosis wit